Ridaforolimus as a single agent in advanced endometrial cancer: Results of a single-arm, phase 2 trial

N. Colombo, D. S. McMeekin, P. E. Schwartz, C. Sessa, P. A. Gehrig, R. Holloway, P. Braly, D. Matei, A. Morosky, P. F. Dodion, M. H. Einstein, F. Haluska

Research output: Contribution to journalArticle

81 Scopus citations

Fingerprint Dive into the research topics of 'Ridaforolimus as a single agent in advanced endometrial cancer: Results of a single-arm, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences